$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2022 Q3 Form 10-Q Financial Statement

#000162828022021068 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q3
Revenue $31.58M $32.41M $38.28M
YoY Change -17.52% -29.37% 401.56%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $31.62M $32.74M $37.39M
YoY Change -15.41% 83.33% 164.96%
% of Gross Profit
Research & Development $81.12M $72.18M $63.28M
YoY Change 28.2% 21.67% 51.17%
% of Gross Profit
Depreciation & Amortization $2.660M $2.200M $2.504M
YoY Change 6.23% 37.5% 47.29%
% of Gross Profit
Operating Expenses $115.4M $105.3M $103.2M
YoY Change 11.86% 35.45% 78.64%
Operating Profit -$72.91M
YoY Change 128.78%
Interest Expense $1.583M $1.240M $1.148M
YoY Change 37.89% -3.13% -49.43%
% of Operating Profit
Other Income/Expense, Net $90.00K $863.0K $363.0K
YoY Change -75.21% -55.61% -162.59%
Pretax Income -$82.16M -$72.05M -$63.37M
YoY Change 29.64% 140.76% 30.85%
Income Tax $3.785M $0.00 $2.000K
% Of Pretax Income
Net Earnings -$85.51M -$72.05M -$63.37M
YoY Change 34.93% 140.76% 30.85%
Net Earnings / Revenue -270.82% -222.28% -165.54%
Basic Earnings Per Share -$0.68
Diluted Earnings Per Share -$807.6K -$0.68 -$607.8K
COMMON SHARES
Basic Shares Outstanding 105.8M shares 105.8M shares
Diluted Shares Outstanding 105.8M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $376.4M $416.5M $311.1M
YoY Change 20.98% -19.33% 36.11%
Cash & Equivalents $108.0M $139.4M $184.4M
Short-Term Investments $268.4M $277.1M $126.7M
Other Short-Term Assets $20.20M $8.892M $2.191M
YoY Change 822.14% -0.89% 22.95%
Inventory
Prepaid Expenses $7.289M $6.761M $4.362M
Receivables $1.410M $239.0K $10.26M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $405.3M $432.4M $384.6M
YoY Change 5.38% -17.79% 19.3%
LONG-TERM ASSETS
Property, Plant & Equipment $110.3M $71.90M $48.68M
YoY Change 126.6% 50.47% 57.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $105.9M $165.9M $245.6M
YoY Change -56.89% 29.25% 78.61%
Other Assets $218.0K $275.0K $272.0K
YoY Change -19.85% 1.1% 3.03%
Total Long-Term Assets $286.6M $319.4M $325.6M
YoY Change -11.95% 52.84% 62.67%
TOTAL ASSETS
Total Short-Term Assets $405.3M $432.4M $384.6M
Total Long-Term Assets $286.6M $319.4M $325.6M
Total Assets $691.9M $751.8M $710.1M
YoY Change -2.56% 2.29% 35.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.868M $5.894M $9.457M
YoY Change -69.67% -41.28% 38.48%
Accrued Expenses $46.86M $32.50M $14.00M
YoY Change 234.66% -5.7% 159.81%
Deferred Revenue $74.10M $84.29M $111.1M
YoY Change -33.28% 475.68%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $138.9M $128.2M $146.5M
YoY Change -5.25% -34.4% 260.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $134.8M $149.4M $154.8M
YoY Change -12.95% 45.6% 673.95%
Total Long-Term Liabilities $134.8M $149.4M $154.8M
YoY Change -12.95% 45.6% 672.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $138.9M $128.2M $146.5M
Total Long-Term Liabilities $134.8M $149.4M $154.8M
Total Liabilities $273.6M $277.6M $301.3M
YoY Change -9.2% -6.86% 396.21%
SHAREHOLDERS EQUITY
Retained Earnings -$820.8M -$735.2M -$644.7M
YoY Change 27.31% 27.95%
Common Stock $1.219B $1.189B $1.054B
YoY Change 15.74% 9.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $398.5M $453.9M $408.8M
YoY Change
Total Liabilities & Shareholders Equity $691.9M $751.8M $710.1M
YoY Change -2.56% 2.29% 35.91%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q3
OPERATING ACTIVITIES
Net Income -$85.51M -$72.05M -$63.37M
YoY Change 34.93% 140.76% 30.85%
Depreciation, Depletion And Amortization $2.660M $2.200M $2.504M
YoY Change 6.23% 37.5% 47.29%
Cash From Operating Activities -$68.67M -$68.85M -$24.12M
YoY Change 184.72% 132.13% 121.26%
INVESTING ACTIVITIES
Capital Expenditures -$32.71M -$9.536M -$8.199M
YoY Change 298.96% 140.32% 331.53%
Acquisitions
YoY Change
Other Investing Activities $69.16M $70.81M -$110.0M
YoY Change -162.84% -554.96% 71.95%
Cash From Investing Activities $36.45M $61.28M -$118.2M
YoY Change -130.82% -413.72% 79.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 855.0K 60.60M 815.0K
YoY Change 4.91% 2072.04% -18.5%
NET CHANGE
Cash From Operating Activities -68.67M -68.85M -24.12M
Cash From Investing Activities 36.45M 61.28M -118.2M
Cash From Financing Activities 855.0K 60.60M 815.0K
Net Change In Cash -31.37M 53.03M -141.5M
YoY Change -77.84% -214.29% 86.74%
FREE CASH FLOW
Cash From Operating Activities -$68.67M -$68.85M -$24.12M
Capital Expenditures -$32.71M -$9.536M -$8.199M
Free Cash Flow -$35.96M -$59.31M -$15.92M
YoY Change 125.88% 130.86% 76.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000879407
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38042
dei Entity Registrant Name
EntityRegistrantName
ARROWHEAD PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0408024
dei Entity Address Address Line1
EntityAddressAddressLine1
177 E. Colorado Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Pasadena
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91105
dei City Area Code
CityAreaCode
626
dei Local Phone Number
LocalPhoneNumber
304-3400
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ARWR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
105848963 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139439000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
184434000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
239000 usd
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10255000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6761000 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4362000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
8892000 usd
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
2191000 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
126728000 usd
CY2022Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
277057000 usd
CY2021Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
56627000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
432388000 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
384597000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71904000 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48675000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12387000 usd
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13663000 usd
CY2022Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
165920000 usd
CY2021Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
245595000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68908000 usd
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17346000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
275000 usd
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
272000 usd
CY2022Q2 us-gaap Assets
Assets
751782000 usd
CY2021Q3 us-gaap Assets
Assets
710148000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5894000 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9457000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32499000 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14001000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2648000 usd
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9773000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2883000 usd
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2250000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
84288000 usd
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
111055000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
128212000 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
146536000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78231000 usd
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23295000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
71162000 usd
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
131495000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
149393000 usd
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
154790000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105795000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105795000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104327000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
198000 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
197000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-735244000 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-644692000 usd
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
104327000 shares
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1189113000 usd
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1053386000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-140000 usd
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-69000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
453927000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
408822000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
20250000 usd
CY2021Q3 us-gaap Minority Interest
MinorityInterest
0 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
474177000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
408822000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
751782000 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
710148000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32412000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45891000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
211656000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
100004000 usd
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
72180000 usd
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
59325000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
213930000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
140576000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33141000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18434000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
92403000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43581000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
105321000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
77759000 usd
us-gaap Operating Expenses
OperatingExpenses
306333000 usd
us-gaap Operating Expenses
OperatingExpenses
184157000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-72909000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-31868000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-94677000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-84153000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1240000 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1280000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3450000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4972000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-377000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
664000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
675000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1707000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
863000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1944000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4125000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6679000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72046000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29924000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-90552000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77474000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-72046000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-29924000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90552000 usd
us-gaap Net Income Loss
NetIncomeLoss
-77474000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105753000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
104099000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105273000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103569000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105753000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
104099000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105273000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103569000 shares
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-71000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-72079000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29964000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-90623000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-77430000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
445549000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18549000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2756000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-29924000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
436890000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
452266000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33391000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
599000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-33000 usd
CY2022Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
60000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90552000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
474177000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-72046000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
474177000 usd
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
461779000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42051000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10490000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44000 usd
us-gaap Net Income Loss
NetIncomeLoss
-77474000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
436890000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
408822000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
91697000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4281000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-71000 usd
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
60000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90552000 usd
us-gaap Net Income Loss
NetIncomeLoss
-77474000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
91697000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
42051000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7761000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5763000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-5755000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1387000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-2013000 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-142000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10016000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-174000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8876000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2895000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-87100000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
211392000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3563000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3208000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1713000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
13682000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3672000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
685000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-67464000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
195341000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20066000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15368000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
223391000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
95195000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
201595000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
87130000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41862000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23433000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4331000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10490000 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
60000000 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
64331000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10490000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-44995000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
182398000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
184434000 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
143583000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
139439000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
325981000 usd
CY2022Q2 arwr Tax Increment Financing Award
TaxIncrementFinancingAward
16000000 usd
us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
2500000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139400000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7400000 usd
CY2022Q2 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
277100000 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2022Q2 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
165900000 usd
arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
-31000000 usd
CY2022Q2 arwr Computers Software Office Equipment And Furniture Gross
ComputersSoftwareOfficeEquipmentAndFurnitureGross
2210000 usd
CY2021Q3 arwr Computers Software Office Equipment And Furniture Gross
ComputersSoftwareOfficeEquipmentAndFurnitureGross
2170000 usd
CY2022Q2 arwr Research Equipment Gross
ResearchEquipmentGross
31678000 usd
CY2021Q3 arwr Research Equipment Gross
ResearchEquipmentGross
27500000 usd
CY2022Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
42017000 usd
CY2021Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
41524000 usd
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
22338000 usd
CY2021Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
345000 usd
CY2022Q2 us-gaap Land
Land
2996000 usd
CY2021Q3 us-gaap Land
Land
0 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
101239000 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71539000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29335000 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22864000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71904000 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48675000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2200000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1600000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6500000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4500000 usd
CY2022Q2 us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
122300000 usd
CY2022Q2 arwr Cash Equivalents Held To Maturity And Marketable Securities Amortized Cost
CashEquivalentsHeldToMaturityAndMarketableSecuritiesAmortizedCost
468302000 usd
CY2022Q2 arwr Cash Equivalents Held To Maturity And Marketable Securities Gross Unrealized Gains
CashEquivalentsHeldToMaturityAndMarketableSecuritiesGrossUnrealizedGains
32000 usd
CY2022Q2 arwr Cash Equivalents Held To Maturity And Marketable Securities Gross Unrealized Losses
CashEquivalentsHeldToMaturityAndMarketableSecuritiesGrossUnrealizedLosses
7968000 usd
CY2022Q2 arwr Cash Equivalents Held To Maturity And Marketable Securities Fair Value
CashEquivalentsHeldToMaturityAndMarketableSecuritiesFairValue
460366000 usd
CY2021Q3 arwr Cash Equivalents Held To Maturity And Marketable Securities Amortized Cost
CashEquivalentsHeldToMaturityAndMarketableSecuritiesAmortizedCost
429703000 usd
CY2021Q3 arwr Cash Equivalents Held To Maturity And Marketable Securities Gross Unrealized Gains
CashEquivalentsHeldToMaturityAndMarketableSecuritiesGrossUnrealizedGains
1954000 usd
CY2021Q3 arwr Cash Equivalents Held To Maturity And Marketable Securities Gross Unrealized Losses
CashEquivalentsHeldToMaturityAndMarketableSecuritiesGrossUnrealizedLosses
856000 usd
CY2021Q3 arwr Cash Equivalents Held To Maturity And Marketable Securities Fair Value
CashEquivalentsHeldToMaturityAndMarketableSecuritiesFairValue
430801000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1300000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
400000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1700000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700000 usd
CY2022Q2 arwr Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
5200000 usd
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13663000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1276000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
12387000 usd
CY2022Q2 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105795456 shares
CY2022Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3400000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1600000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
6000000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3600000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
200000 usd
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
100000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
500000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
600000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1309000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5802000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8094000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
11800000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12313000 usd
CY2022Q2 arwr Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
114109000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
153427000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
72313000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
81114000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3400000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2200000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y3M18D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3456239 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
106801 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
43.68
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
506596 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.45
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2842842 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.60
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
55434252 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2370089 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
52941990 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.011
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.86
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.904
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
48.64

Files In Submission

Name View Source Status
0001628280-22-021068-index-headers.html Edgar Link pending
0001628280-22-021068-index.html Edgar Link pending
0001628280-22-021068.txt Edgar Link pending
0001628280-22-021068-xbrl.zip Edgar Link pending
arwr-20220630.htm Edgar Link pending
arwr-20220630.xsd Edgar Link pending
arwr-20220630xexx311.htm Edgar Link pending
arwr-20220630xexx312.htm Edgar Link pending
arwr-20220630xexx321.htm Edgar Link pending
arwr-20220630xexx322.htm Edgar Link pending
arwr-20220630_cal.xml Edgar Link unprocessable
arwr-20220630_def.xml Edgar Link unprocessable
arwr-20220630_htm.xml Edgar Link completed
arwr-20220630_lab.xml Edgar Link unprocessable
arwr-20220630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending